VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $697,000 | +45.8% | 30,000 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $478,000 | -23.3% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $623,000 | +44.9% | 30,000 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $430,000 | -17.1% | 30,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $519,000 | +56.8% | 30,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $331,000 | +2106.7% | 30,000 | +2900.0% | 0.00% | – |
| Q4 2016 | $15,000 | -97.2% | 1,000 | -95.1% | 0.00% | -100.0% |
| Q1 2016 | $537,000 | -68.9% | 20,404 | +20.1% | 0.00% | -66.7% |
| Q4 2015 | $1,727,000 | -16.8% | 16,988 | +46.0% | 0.01% | -18.2% |
| Q3 2015 | $2,075,000 | -11.2% | 11,632 | +10.5% | 0.01% | 0.0% |
| Q2 2015 | $2,338,000 | +11.8% | 10,526 | 0.0% | 0.01% | +22.2% |
| Q1 2015 | $2,091,000 | +6236.4% | 10,526 | +3948.5% | 0.01% | – |
| Q2 2014 | $33,000 | -2.9% | 260 | 0.0% | 0.00% | – |
| Q1 2014 | $34,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |